Page 172 - Abt News Today

Kornitzer Capital Management Inc. KS trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 0.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 303,616 shares of the healthcare product maker’s stock after selling 2,193 shares during the period. Abbott Laboratories accounts for approximately 0.7% of Kornitzer Capital Management Inc. […]

Abbott Laboratories (ABT) shares are gaining more than 5 percent on Wednesday morning trade after the company reported first-quarter profit that beat estimates. The company reaffirmed full-year earnings per share in a range of $4.

Mission Wealth Management LP boosted its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 34.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 21,015 shares of the healthcare product maker’s stock after purchasing an additional 5,394 shares […]

Hilltop Wealth Advisors LLC acquired a new stake in Abbott Laboratories (NYSE:ABT – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 2,005 shares of the healthcare product maker’s stock, valued at approximately $220,000. Several other large investors also recently […]

Healthcare stocks have sputtered this year after performing well in 2022. A Barrons screen has identified stocks that are poised to outperform for the rest of the year.

Congress Wealth Management LLC DE grew its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 0.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 100,086 shares of the healthcare product maker’s stock after purchasing an additional 117 shares during the period. Congress Wealth […]

Silver Oak Securities Incorporated lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 4.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 7,507 shares of the healthcare product maker’s stock after selling 371 shares during the quarter. Silver Oak Securities […]

Magnus Financial Group LLC lowered its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 11.0% during the fourth quarter, HoldingsChannel reports. The firm owned 2,977 shares of the healthcare product maker’s stock after selling 367 shares during the period. Magnus Financial Group LLC’s holdings in Abbott Laboratories were worth $327,000 at the end of […]

Abbott Laboratories (NYSE:ABT – Get Rating) saw unusually large options trading on Wednesday. Traders acquired 25,237 call options on the company. This is an increase of 148% compared to the average daily volume of 10,182 call options. Analyst Ratings Changes Several research firms recently issued reports on ABT. Barclays lifted their price target on shares […]

Tobam increased its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 7.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,682 shares of the healthcare product maker’s stock after purchasing an additional 633 shares during the period. Tobam’s holdings in Abbott […]